Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1996468 | Molecular Cell | 2011 | 8 Pages |
SummaryDEPTOR is a recently identified inhibitor of the mTOR kinase that is highly regulated at the posttranslational level. In response to mitogens, we found that DEPTOR was rapidly phosphorylated on three serines in a conserved degron, facilitating binding and ubiquitylation by the F box protein βTrCP, with consequent proteasomal degradation of DEPTOR. Phosphorylation of the βTrCP degron in DEPTOR is executed by CK1α after a priming phosphorylation event mediated by either the mTORC1 or mTORC2 complexes. Blocking the βTrCP-dependent degradation of DEPTOR via βTrCP knockdown or expression of a stable DEPTOR mutant that is unable to bind βTrCP results in mTOR inhibition. Our findings reveal that mTOR cooperates with CK1α and βTrCP to generate an auto-amplification loop to promote its own full activation. Moreover, our results suggest that pharmacologic inhibition of CK1 may be a viable therapeutic option for the treatment of cancers characterized by activation of mTOR-signaling pathways.
Graphical AbstractFigure optionsDownload full-size imageDownload high-quality image (219 K)Download as PowerPoint slideHighlights► In response to mitogens, DEPTOR is degraded via SCFβTrCP ► Binding of DEPTOR to βTrCP requires phosphorylation of the DEPTOR degron ► mTOR and CK1α are required for the phosphorylation of the DEPTOR degron ► Failure to degrade DEPTOR results in mTOR activation defects